Amarin Corp Plc (AMRN)

[sts66]

They've barely dented on-label L sales, generic or brand - what makes you think they're suddenly going to capture a huge number of the ANCHOR population if they get approval? They may eventually, but it ain't gonna happen overnight, not with only a couple hundred sales reps and no advertising.

Let's face it - the company was set up for a BO on ANCHOR approval, not to continue as a biotech - and I expect many of us bought the stock in anticipation of that occurring. Now management has a horrible rep, and rightly so, stock is damaged as a result, investors will be skeptical until they see real revenues coming in. That's why I claim even ANCHOR approval doesn't blast this skywards - the starting pps is just too low now.